News

01.27.23

Press Release

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

SEATTLE, Wash. and VANCOUVER, British Columbia, Jan. 27, 2023 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the Company has issued an inducement grant of stock options to a new employee. Achieve’s Board of…

/Read More

01.09.23

Press Release

Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

Topline Results Remain on Schedule to be Reported in the Second Quarter of 2023 SEATTLE, Wash. and VANCOUVER, British Columbia, January 9, 2023 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the final…

/Read More

12.21.22

Press Release

Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

SEATTLE, Wash and VANCOUVER, British Columbia, December 21, 2022 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,459,328 covering the mesylate…

/Read More

11.15.22

Press Release

Achieve Life Sciences Announces Private Placement of $18.9 Million

SEATTLE, Wash. and VANCOUVER, British Columbia, November 15, 2022 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that it has entered into definitive agreements for a private placement of its securities for gross proceeds…

/Read More

11.14.22

Press Release

Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update

Company to host conference call at 4:30 PM EST today, November 14, 2022 SEATTLE, WA and VANCOUVER, British Columbia, November 14, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced third quarter…

/Read More